Palantir Just Crushed Earnings. So Why Is the Stock Down?

Palantir posted very strong Q1 fundamentals, with U.S. commercial revenue up 133% year over year to $595 million, consolidated revenue up 85%, and operating margin at 46%. The article argues the stock continues to fall mainly because of valuation, citing a peak price-to-sales ratio of 100 entering 2026 and current multiples of 67 P/S and 153 P/E. Overall message is positive on the business but cautious to bearish on the stock at current levels.

Analysis

The setup is less about PLTR’s execution and more about the market rediscovering duration risk in a name priced for near-perfect compounding. When a software asset already capitalizes years of growth at a premium multiple, incremental upside from another strong quarter is mechanically overwhelmed by any small reset in implied terminal margins or growth persistence. That makes the stock especially vulnerable to de-rating even while fundamentals improve, because the next leg is driven by multiple compression rather than earnings revision.

The more interesting second-order effect is that PLTR’s outperformance has likely become a funding source for crowded AI beta elsewhere: any sustained drawdown can rotate speculative capital back into lower-multiple AI beneficiaries with clearer path-to-cash-flow, especially infrastructure and semiconductor names. The article’s framing also suggests a narrative risk for the broader “AI software winner-takes-all” trade — if the market stops rewarding revenue acceleration with expansion multiples, peers with similar top-line velocity but less extreme valuation could see relative re-rating pressure ease.

The contrarian edge is that the near-term selloff may still be too shallow if rates stay sticky or if the market becomes less forgiving on extreme P/S names. But the opposite tail risk is also real: if commercial RPO/remaining deal metrics keep compounding into the next 1-2 quarters, shorting outright becomes expensive because the company can grow into the multiple faster than valuation skeptics expect. The catalyst window is months, not days; this is a position where the path is dominated by multiple compression or expansion around earnings, not daily tape action.

Net: this is a high-quality business trapped in a valuation regime shift. The trade is not to fight the business; it is to express the view that the market will prefer cheaper AI monetizers with less embedded perfection, unless PLTR continues to deliver upside so large that it forces the market to re-anchor its terminal assumptions.

Key Decisions for Investors

• Avoid initiating fresh outright long PLTR here; if already long, consider trimming into strength and keeping only a core position, because upside requires continued >50% revenue growth plus sustained margin expansion to overcome multiple risk over the next 2-4 quarters.
• For a valuation-normalization expression, use put spreads in PLTR around the next earnings cycle rather than naked shorts; the risk/reward is better because the name can re-rate sharply higher on any guide-up, but downside convexity remains meaningful if the market keeps compressing the P/S multiple.
• Pair trade: long NVDA / short PLTR on a 3-6 month horizon. NVDA has better earnings visibility and a more defensible cash-flow multiple, while PLTR’s valuation is most exposed to any slowing in acceleration; this isolates AI exposure while reducing pure multiple risk.
• If looking for a cheaper AI software winner, rotate toward names with visible enterprise adoption and lower starting multiples rather than chasing PLTR. The relative trade is to own AI monetization with less terminal-value sensitivity, not the most crowded compounder.
• Set a tactical trigger: if PLTR sustains a further 15-20% drawdown without fundamental deterioration, reassess for a mean-reversion trade only after the next quarterly print confirms deal-value momentum; before that, the risk/reward remains asymmetric against new longs.